Enhanced secretion of cardiac hepatocyte growth factor from an infarct region is associated with less severe ventricular enlargement and improved cardiac function

Journal of the American College of Cardiology

Volumn 36, Issue 1, 2000, Pages 115-121

  Yasuda, Satoshi ^a   Goto, Yoichi ^a   Baba, Takeshi ^a   Satoh, Toru ^a   Sumida, Hitoshi ^a   Miyazaki, Shunichi ^a   Nonogi, Hiroshi ^a  

^a Division of Cardiology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; SCATTER FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD SAMPLING; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY REPERFUSION; HEART CATHETERIZATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; MALE; PRIORITY JOURNAL; SECRETION; WOUND HEALING;

BIOLOGICAL MARKERS; CARDIAC OUTPUT; CELL SURVIVAL; CORONARY ANGIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART CATHETERIZATION; HEART VENTRICLES; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 0033910377     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00675-6     Document Type: Article

References (35)

1. Nakamura T., Nishizawa T., Hagiya M., et al. Molecular cloning and expression of hepatocyte growth factor. Nature. 342:1989;440-443.
2. Matsumoto K., Nakamura T. Emerging multipotent aspects hepatocyte growth factor. J Biochem. 119:1996;591-600.
3. Ono K., Matsumori A., Shioi T., Furukawa Y., Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 95:1997;2552-2558.
4. Nagaya N., Nishikimi T., Goto Y., et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J. 135:1998;21-28.
5. White H.D., Norris R.M., Brown M.A., Brandt P.W.T., Whitlock R.M.L., Wild C.J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 76:1987;44-51.
6. Braunwald E. Heart Disease. 5th ed. 1997;1195-1196 WB Saunders, Philadelphia.
7. Weber K.T. Extracellular matrix remodeling in heart failure a role of de novo angiotensin II generation . Circulation. 96:1997;4065-4082.
8. Grant D.S., Kleinmann H.K., Goldberg I.D., et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA. 90:1993;1937-1941.
9. Nakamura Y., Morishita R., Higaki J., et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor . J Hypertens. 14:1996;1067-1072.
10. Belle E.V., Witzenbichler B., Chen D., et al. Potential angiogenetic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor the case for paracrine amplification of angiogenesis . Circulation. 97:1998;381-390.
11. Nakamura Y., Morishita R., Nakamura S., et al. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 28:1996;409-413.
12. Nakano N., Moriguchi A., Morishia R., et al. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats. Hypertension. 30:1997;1448-1454.
13. Nakamura S., Moriguchi A., Morishita R., et al. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun. 242:1998;238-243.
14. Dunsmore S.E., Rubin J.S., Kovacs S.O., Chedid M., Parks W.C., Welgus H.G. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem. 271:1996;24576-24582.
15. Matsuda Y., Matsumoto K., Yamada A., et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 26:1997;81-89.
16. Schaper W., Kubin T. Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? Circulation. 95:1997;2471-2472.
17. Sumida H., Yasue H., Yoshimura M., et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol. 25:1995;1105-1110.
18. Clemente C.D. Gray's Anatomy. 30th ed. 1985;798-799 Lea & Febiger, Philadelphia.
19. Pejkovic B., Bogdanovic D. The great cardiac vein. Surg Radiol Anat. 14:1992;23-28.
20. Taniguchi T., Toi M., Tominaga T. Rapid induction of hepatocyte growth factor by heparin. Lancet. 344:1994;470.
21. Matsumoto K., Nakamura T. Heparin functions as a hepatotrophic factor by inducing production of hepatocyte growth factor. Biochem Biophys Res Commun. 227:1996;455-461.
22. Raff G.L., Glanz S.A. Volume loading slows left ventricular isovolumic relaxation rate evidence of load-dependent relaxation in the intact dog . Circ Res. 48:1981;813-824.
23. Tsubouchi H., Niitani Y., Hiroko S., et al. Levels of the human hepatocyte growth factor in serum of patients with various diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 13:1991;1-5.
24. Arakaki N., Kawakami S., Nakamura O., et al. Evidence of the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology. 22:1995;1728-1784.
25. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction . Circulation. 96:1997;509-516.
26. Matsumori A., Furukawa Y., Hashimoto T., et al. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun. 221:1996;391-395.
27. Ku D.D. Coronary vascular reactivity after acute myocardial ischemia. Science. 218:1982;576-578.
28. Quillen J.E., Sellke F.W., Brooks L.A., Harrison D.G. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation. 82:1990;586-594.
29. Bauters C., Asahara T., Zheng L.P., et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation. 91:1995;2802-2809.
30. Harada K., Friedman M., Lopez J.J., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 270:1996;H1791-H1802.
31. Miller S.B., Martin D.R., Kissane J., Hammermann M.R. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rats. Am J Physiol. 266:1994;F129-F134.
32. Ueda H., Sawa Y., Matsumoto K., et al. Gene transfection of hepatocyte growth factor attenuates reperfusion injury in the heart. Ann Thorac Surg. 67:1999;1726-1731.
33. Morishita R., Aoki M., Nakamura S., et al. Potential role of a novel vascular modulator, hepatocyte growth factor (HGF), in cardiovascular disease characterization and regulation of local HFG system . J Atheroscler Thromb. 4:1997;12-19.
34. Taniyama Y., Morishita R., Matsumoto K., Ogihara T. Prevention of myocardial injury and fibrosis by angiotensin II blockade in cardiomyopathic hamster potential contribution of a novel anti-fibrotic factor, hepatocyte growth factor (HGF) (abstr) . Circulation. 98:1998;I179.
35. Yasuda S., Goto Y., Sumida H., et al. Angiotensin-converting enzyme inhibition restores hepatocyte growth factor production in patients with congestive heart failure. Hypertension. 33:1999;1374-1378.